Millions of Americans are infected by the hepatitis C virus. The FDA approval for Zepatier provides patients with genotype 1 and 4 infections another treatment option to improve prognosis for their condition.
Millions of Americans are infected by the hepatitis C virus. The FDA approval for Zepatier provides patients with genotype 1 and 4 infections another treatment option to improve prognosis for their condition.
Share this Article
Recommended